Nuwellis, Inc. (NASDAQ:NUWE – Free Report)’s stock is set to reverse split on the morning of Friday, June 28th. The 1-35 reverse split was announced on Friday, June 28th. The number of shares owned by shareholders will be adjusted after the closing bell on Friday, June 28th.
Nuwellis Stock Performance
NUWE stock traded down $0.07 during mid-day trading on Wednesday, hitting $0.14. The company had a trading volume of 11,182,318 shares, compared to its average volume of 3,782,285. The firm has a market cap of $2.58 million, a PE ratio of -0.02 and a beta of 0.49. The stock’s fifty day moving average price is $0.23 and its two-hundred day moving average price is $0.40. Nuwellis has a 12 month low of $0.12 and a 12 month high of $2.85.
Nuwellis (NASDAQ:NUWE – Get Free Report) last posted its earnings results on Tuesday, May 7th. The company reported ($0.60) earnings per share for the quarter. The business had revenue of $1.86 million during the quarter. Nuwellis had a negative return on equity of 316.90% and a negative net margin of 202.97%.
About Nuwellis
Nuwellis, Inc, a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics.
Read More
- Five stocks we like better than Nuwellis
- 3 Fintech Stocks With Good 2021 Prospects
- Stock Impact: McDonald’s Price War with Starbucks, Wendy’s
- 5 discounted opportunities for dividend growth investors
- General Mills Q4 Sales Miss Expectations, Triggering Stock Drop
- About the Markup Calculator
- Enovix Stock Rises 35% in Short-Squeeze: This Rally Has Legs
Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.
